Skip to main content
Jun Chen, MD, Nephrology, Plano, TX

Jun Chen MD

Nephrology•Plano, TX

Physician

Join to View Full Profile

  • 6300 W Parker RdSte 224Plano, TX 75093

  • Phone+1 469-574-0464

  • Fax+1 469-574-0471

Dr. Chen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Chen's Full ProfileAlready have an account?

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Nephrology, 2006 - 2008
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2002 - 2005
  • Beijing Medical University
    Beijing Medical UniversityClass of 1992

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2005 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Nephrology
    American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Intergy EHR, Greenway Health, LLC, 2011

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Loss of Function of NF1 Is a Mechanism of Acquired Resistance to Endocrine Therapy in Lobular Breast Cancer  
    A V Lee, Y X Feng, J Chung, S Ali, J Chen, J S Ross, Annals of Oncology
  • Tissue Plasminogen Activator Promotes White Matter Integrity and Functional Recovery in a Murine Model of Traumatic Brain Injury  
    Jun Chen, MD, Proceedings of the National Academy of Sciences

Press Mentions

  • Shanghai Public Health Clinical Center Completed Patient Enrollment in Clinical Study of PD-L1 Antibody ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV Infection
    Shanghai Public Health Clinical Center Completed Patient Enrollment in Clinical Study of PD-L1 Antibody ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV InfectionSeptember 15th, 2022
  • Fast-Acting Immune Cells Provide Powerful Protection Against Stroke
    Fast-Acting Immune Cells Provide Powerful Protection Against StrokeAugust 1st, 2022
  • Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
    Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV InfectionJuly 3rd, 2022
  • Join now to see all

Grant Support

  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • A soft magnetoelastic microneedle patch for rapid skin cancer screeningUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2029
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Adiponectin on cerebrovascular regulation in vascular cognitive impairment and dementia (VCID)UNIVERSITY OF PITTSBURGH AT PITTSBURGH2022–2026
  • Adiponectin on cerebrovascular regulation in vascular cognitive impairment and dementia (VCID)UNIVERSITY OF PITTSBURGH AT PITTSBURGH2022–2026
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturationENDOMIMETICS, LLC2016–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Jun Chen, Dr. Jun Chen, MD, Dr. J Chen